Dr. Mabel Chu, DO

Dr. Chu practices at Oroville Hospital in Oroville, California, part of Oro Hospital.

Dr. Chu's NPI, 1285880708, was assigned on August 15, 2008. Dr. Chu graduated from Touro University California - Vallejo in 2008. Dr. Chu holds California license 20A13612.

Dr. Chu's primary practice is Oroville Hospital, at 2767 Olive Highway, Oroville, CA 95966 in Butte County. The practice phone is (530) 533-8500.

Dr. Chu's primary practice is Oroville Hospital in Oroville, California, part of Oro Hospital. Dr. Chu is also affiliated with Enloe Health. The medical group on file is Oro Health Professional. Dmand AI also links Dr. Chu to 2 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chu practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Chu's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Chu is board certified in general vascular surgery by the AOA Board of Surgery. Dmand AI has Dr. Chu's licenses on file in 6 states: California, Tennessee, Oregon, Michigan, Ohio and Nevada.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Chu treats.

CMS data shows 386 Medicare services from Dr. Chu across 13 procedure codes in 2024, for 207 Medicare patients. Medicare paid $33,895 for them.

CMS counts 207 Medicare patients who saw Dr. Chu in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 4.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chu's median patient age at 70, with 37% women.

In 2024, Dr. Chu wrote 215 Medicare Part D claims for 74 patients. 89% of them were for generic drugs. CMS names the drug for 166 of them, across 5 drugs with 11 or more claims each, at $15,600 in total drug cost. In 2023, CMS named 170 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Chu for performance year 2024, reported through an alternative payment model (APM). Dr. Chu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chu as offering telehealth. CMS counts 16 procedures of leg revascularization (restoring blood flow) by Dr. Chu, more than 74% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Chu in 2014.

CMS Open Payments shows 223 general payments to Dr. Chu from 29 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Boston Scientific Corporation paid the most, $3,930.

Dmand AI lists 1 award for Dr. Chu.

Dr. Chu graduated from Touro University California - Vallejo in 2008. Dr. Chu is a member of ACS and AOA.

Dr. Chu is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.